Important Announcement: Regarding Coronavirus
We are looking forward to welcoming you to the upcoming 2nd Clinical Trial Risk Management Seminar. The safety and health of our attendees and partners is our number one priority. Please be assured that we are monitoring the situation very closely and are in constant contact with our speakers, sponsors and attendees. Should there be any changes to the current status, we will take account of any recommendations from the relevant federal and state authorities, and the municipal health authorities, and implement all appropriate instructions.
Based on the success of our first West Coast Clinical Risk Management Seminar, we are pleased announce the second annual event, taking place June 23-24 in San Francisco, CA. This event features two days of interactive workshops, presentations, panels and roundtables, all developed for smaller companies with limited resources.
Join us to gain a comprehensive education on
clinical risk management and the tools to assess, maintain and mitigate risk to ensure compliance.
Top Reasons to Attend
Having successfully established a series of clinical quality events on the East Coast and in Europe, our Events brought their well-known conference series to San Francisco in 2019, with a
Clinical Trial Risk Management Seminar geared towards biotechnology and biopharmaceutical companies. With a successful first year under our belts, we are excited to come back and continue to provide the educational needs for smaller companies with limited resources.
- Understand the value of risk-based approaches to ensure compliance using limited resources.
- Ensure your clinical quality risk management plan covers all the critical elements to ensure GCP compliance.
- Develop an effective strategy to work with and oversee your CRO partners to ensure transparency, compliance and productivity.
- Learn the tools to achieve a constant state of inspection-readiness.
Who Should Attend?
This conference is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical trial service providers whose responsibilities involve the following:
- Good Clinical Practice (GCP)
- Clinical Quality Assurance (CQA)
- Clinical Quality Control (CQC)
- Clinical Trial Operations/Management
- Clinical Research
- Quality Management/ Global Quality Management
- Audits/Inspections
- Compliance/Global Compliance
- Data Management/Systems Operations
- Clinical Monitoring
- Regulatory Affairs
- Safety and Risk Management/Operations
The event is also relevant to clinical QA, compliance and operations professionals from:
- Quality Service Providers and Consulting Companies
- CROs
- Central, Imaging and ECG Labs
- Investigative Sites
- IRBs
- Data Management and Software Vendors
- Safety Reporting Vendors
2019 Speakers Included
- Pam Dellea-Giltner, B.D., MBA, CCRA, President, PDG CLINICAL CONSULTING, LLC
- Julia Moore, Associate Director, Clinical Operations, SANGAMO THERAPEUTICS, INC.
- Liz Wool, President, WOOL CONSULTING GROUP, INC
- Todd Johnson, Principal Consultant, Organizational Solutions, HALLORAN CONSULTING GROUP
- Sheila Gwizdak, Principal Consultant, Quality, HALLORAN CONSULTING GROUP
- Michele Weitz, Senior Director, GCP Compliance Operations, CLOVIS ONCOLOGY
- David Otis, Director GCP & GLP Quality, IOVANCE BIOTHERAPEUTICS, INC.
- Angeline Tan, Head, Clinical Quality Assurance, PHARMACYCLICS
- Caro Unger, Senior Manager, Clinical Operations, CLOVIS ONCOLOGY
- Matthew Burtt, Director, Clinical QA, ABBVIE
The full agenda is not yet available for this event.
Follow this event to receive an alert when the agenda becomes available.
Venue
San Francisco Marriott Union Square
480 Sutter Street, 94108
San Francisco, CA, USA
Room Rate: $309 + tax
Reservations cut-off date: June 2, 2020
To make reservations please call (415) 398 -8900 and 1 (800) 228-9290 and request the negotiated rate for ExL's 2nd Clinical Risk Management Seminar.
